Navigation Links
Sanofi Pasteur Announces Shipment of First Lots of 2013-2014 Seasonal Influenza Vaccine in U.S.
Date:7/25/2013

SWIFTWATER, Pa., July 25, 2013 /PRNewswire/ -- Sanofi Pasteur, the vaccines division of Sanofi (EURONEXT: SAN and NYSE: SNY), announced today that the first lots of Fluzone® (Influenza Virus Vaccine) for the 2013-2014 season have been released by the U.S. Food and Drug Administration (FDA) for U.S. distribution and were shipped July 24. This shipment represents the first of more than 60 million doses of seasonal influenza vaccine the company plans to deliver to U.S. health care providers this fall. Influenza vaccine is anticipated to be available to the public from local health care providers and pharmacies in August.

"Although influenza disease typically peaks in the U.S. during the winter, the virus can circulate at any time of year, and in fact, last year, reports of increased levels of influenza disease began in the fall," said David P. Greenberg, M.D., Vice President, U.S. Scientific and Medical Affairs. "Annual immunization of more than 130 million people in a few months is a huge undertaking for health care providers each year, and that is why as the largest producer of influenza vaccine in the U.S., our goal is to deliver a reliable supply of influenza vaccine to support health care providers in planning their fall clinics."

New for 2013-2014

For the 2013-2014 season, two new influenza virus strains have been included in the trivalent seasonal influenza vaccine. There is a new A(H3N2) antigen and a new influenza B antigen. The A(H1N1) component of the vaccine is unchanged since the 2009 pandemic. Last season, influenza A(H3N2) disease predominated in the U.S., and it was particularly severe in older adults.

The 2013-2014 influenza season will be the first in which quadrivalent influenza vaccines will be available in the U.S. Until this year, seasonal influenz
'/>"/>

SOURCE Sanofi Pasteur
Copyright©2012 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7 8

Related medicine technology :

1. Sanofi Pasteur Presents Pediatric Data on Investigational Quadrivalent Influenza Vaccine
2. Sanofi US Launches Collaborate Activate Innovation Challenge
3. Sanofi Pasteur to add 2D barcode to six more vaccines
4. Sanofi and Regeneron Announce Publication of Phase 2 Results with LDL Cholesterol-Lowering PCSK9 Antibody in the New England Journal of Medicine
5. Sanofi and Regeneron Announce Patient Enrollment in Cardiovascular Outcomes Trial with Antibody to PCSK9 for Hypercholesterolemia
6. Sanofi and T1D Exchange to Launch Worldwide Study to Investigate Factors for Optimal Care for Young People with Diabetes
7. Sanofi Donates $500,000 to Hurricane Sandy for Immediate and Long-Term Relief Efforts
8. Phase II Trial of Sanofi JAK2 Inhibitor in Myelofibrosis Met Primary Endpoint
9. Sanofi Launches Breakthrough Technology for Cardiovascular and Vascular Surgery Procedures
10. Zacks Bull and Bear of the Day Highlights: Smithfield Foods, Logitech International, Sanofi, Isis Pharmaceuticals and Aegerion Pharmaceuticals
11. Sanofi New Drug Application for Lixisenatide Accepted for Review by FDA
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:3/2/2015)... , March 2, 2015  Tandem Diabetes Care®, ... company and manufacturer of the t:slim® and t:flex™ Insulin ... announced public offering of common stock have exercised their ... common stock at a price to the public of ... the offering is expected to be $64.8 million, after ...
(Date:3/2/2015)... , March 2, 2015 For the past 15 years, ... per year in the U.S. alone (U.S. Census Bureau 2012). Of ... minor fender benders BUT there are quite a few where the ... intrusion, which can obstruct the seatbelt release button or occupant injury. ... in any serious accidents in their lifetime but may still be ...
(Date:3/2/2015)... -- Leading patient advocacy organization Fight Colorectal Cancer and ... One Million Strong campaign to spotlight colorectal ... funds for colorectal cancer education, research and prevention while ... living in the United States ... every day. Showing Strength for Colorectal Cancer ...
Breaking Medicine Technology:Tandem Diabetes Care Announces Exercise of Option to Purchase Additional Shares in Underwritten Public Offering of Common Stock 2Tandem Diabetes Care Announces Exercise of Option to Purchase Additional Shares in Underwritten Public Offering of Common Stock 3New SuperVizor, an Automobile Escape Tool, Ensures the Safety of Drivers and Passengers on the Road 2Advocacy Group Fight Colorectal Cancer and Bayer HealthCare Join Forces for One Million Strong 2Advocacy Group Fight Colorectal Cancer and Bayer HealthCare Join Forces for One Million Strong 3Advocacy Group Fight Colorectal Cancer and Bayer HealthCare Join Forces for One Million Strong 4Advocacy Group Fight Colorectal Cancer and Bayer HealthCare Join Forces for One Million Strong 5
... , July 25, 2011 Pharmasset, Inc. (Nasdaq: ... to discovering, developing, and commercializing novel drugs to treat ... for the quarter ended June 30, 2011. ... quarter ended June 30, 2011 compared to $0.2 million ...
... VR Business Sales, Mergers & Acquisitions Charlotte, N.C. ... of Salisbury, NC.  This durable medical equipment provider specializes ... manual and power wheelchairs and scooters. "Penrod ... equipment providers I,ve seen.  The business generated a lot ...
Cached Medicine Technology:Pharmasset Reports Fiscal Third Quarter 2011 Financial Results 2Pharmasset Reports Fiscal Third Quarter 2011 Financial Results 3Pharmasset Reports Fiscal Third Quarter 2011 Financial Results 4Pharmasset Reports Fiscal Third Quarter 2011 Financial Results 5
(Date:3/2/2015)... 2015 New York singer/songwriter Richie ... delivering a plenary address entitled Finding the Music ... of Healing and Recovery at this year’s National ... Executive Summit (BHES).     , With more than 300 ... been recorded by some of the biggest names ...
(Date:3/2/2015)... The minimally invasive surgical instruments ... of 6.1% to reach $14,133.0 million by 2019 ... such as advantages of minimally invasive surgeries over ... minimally invasive surgeries and increasing number of surgical ... global minimally invasive surgical instruments market. , For ...
(Date:3/2/2015)... (PRWEB) March 02, 2015 Atlantic Information ... of AIS’s Directory of Health Plans: 2015 , ... available on the U.S. health plan market, with enrollment ... the United States. , Available as a printed ... of enrollment trends in quick-view tables and charts, as ...
(Date:3/2/2015)... March 02, 2015 In light of ... anticoagulant Xarelto (rivaroxaban) tablets, Ford & Associates ... be helpful for future users, but may come too ... from taking the drug. The FDA has now included ... Adverse Reactions on Xarelto's label. The term “cytolytic hepatitis” ...
(Date:3/2/2015)... March 02, 2015 ProvidaStaff ... for its educational healthcare division to EDU Healthcare ... healthcare services to school systems and students nationwide. , ... to school districts throughout the country,” said Angela M. ... be a better organization and the introduction of EDU ...
Breaking Medicine News(10 mins):Health News:Richie Supa Announced as a Plenary Speaker at NCAD 2015 2Health News:Minimally Invasive Surgical Instrument Market - Global Forecast to 2019 - New Report by MarketsandMarkets 2Health News:Now Available from AIS: 12th Edition of Annual Book Containing Health Plan Enrollment Data, Contact Information 2Health News:Ford & Associates Nationwide Legal Services, A.P.C., Comments on Xarelto Lawsuits Upon FDA Revisions 2Health News:Ford & Associates Nationwide Legal Services, A.P.C., Comments on Xarelto Lawsuits Upon FDA Revisions 3Health News:Ford & Associates Nationwide Legal Services, A.P.C., Comments on Xarelto Lawsuits Upon FDA Revisions 4Health News:ProvidaStaff Announces New Name Change to EDU Healthcare for Its Educational Healthcare Division 2Health News:ProvidaStaff Announces New Name Change to EDU Healthcare for Its Educational Healthcare Division 3
... Children's Research Hospital have created a mouse model of a ... about //the gene therapy used to treat children that caused ... combined immunodeficiency (XSCID), is set into action by a mutation ... system from forming B and T lymphocytes. ...
... The manner of transmission of mosquito-borne viruses is well known; ... make an entry into the blood stream. But what happens ... of its victim. Researchers led by a Howard Hughes Medical ... point at a genetic element which helps the dengue virus ...
... study led by Volker Heussler of the Bernhard Nocht Institute ... malarial //parasite avoids the immune system by killing the liver ... that after infecting man, malarial parasites head to the liver ... was not known how the parasite avoids the immune system. ...
... gene which was identified by Professor Sir David Lane of ... gene using the mice model shows that the gene keeps ... Donehower of Baylor College of Medicine in Houston created some ... cancer. In another set he modified the gene and the ...
... Giving up your regular late-night snack may be hard, and ... change an area of the brain to expect the food// ... discovered. ,By training mice to eat at a ... turns on body-clock genes in a particular area of the ...
... isn't limited to soldiers or witnesses of a horrifying event. ... or heart surgery. Not only does PTSD cause emotional// and ... progression of heart disease, reports the August issue of the ... PTSD is that the trauma comes from within. Sufferers are ...
Cached Medicine News:Health News:Discovery In "Bubble Boy" Disease Gene Therapy 2Health News:Discovery In "Bubble Boy" Disease Gene Therapy 3Health News:Discovery In "Bubble Boy" Disease Gene Therapy 4Health News:The Dengue Virus Unplugged 2Health News:The Dengue Virus Unplugged 3Health News:Timing of Food Consumption Activates Genes in Specific Brain Area 2
For the quantitative in vitro determination of IgE in Human Serum or Plasma....
For the quantitative in vitro determination of IgG in serum and plasma. This product is suitable for use on the Aeroset...
Latex-enhanced immunoturbidimetric assay for the quantitative in vitro determination of C-reactive protein in serum and plasma...
Latex agglutination slide test for the qualitative and semi-quantitative in vitro determination of CRP in serum....
Medicine Products: